Increasing cytotechnologist workload above 100 slides per day using the BD focalpoint GS imaging system negatively affects screening performance

American Journal of Clinical Pathology

Volumn 138, Issue 6, 2012, Pages 811-815

  Levi, Angelique W ^a   Galullo, Philip ^a   Gordy, Kristina ^a   Mikolaiski, Natalia ^a   Schofield, Kevin ^a   Elsheikh, Tarik M ^b   Harigopal, Malini ^a   Chhieng, David C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

BD focalpoint GS; Cytopathology; Gynecologic cytology; Gynecology; Imaging system; Location guided screening; Papanicolaou smear; Sensitivity; SurePath; Workload

Indexed keywords

ARTICLE; CYTOTECHNOLOGIST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; HUMAN EXPERIMENT; MEDICAL DEVICE; NORMAL HUMAN; PERFORMANCE; PRIORITY JOURNAL; SCREENING; SQUAMOUS CELL; WORKLOAD;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; DIAGNOSTIC IMAGING; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MASS SCREENING; MEDICAL LABORATORY PERSONNEL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WORKLOAD;

EID: 84869233509     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPTYDD9G2NCUMF     Document Type: Article

References (11)

1. Wilbur DC, Black-Schaffer WS, Luff RD, et al. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions. Am J Clin Pathol. 2009;132:767-775.
2. Passamonti B, Bulletti S, Camilli M, et al. Evaluation of the FocalPoint GS system performance in an Italian populationbased screening of cervical abnormalities. Acta Cytol. 2007;51:865-871. (Pubitemid 350155956)
3. Bowditch RC, Clarke JM, Baird PJ, et al. Results of an Australian trial using SurePath liquid-based cervical cytology with Focalpoint computer-assisted screening technology [published online ahead of print November 1, 2011]. Diagn Cytopathol.
4. BD Diagnostics. BD FocalPoint GS Imaging System Product Insert. Burlington NC: BD Diagnostics; 2011. Available at: http://www.bd.com/tripath/ downloads/msds-pi/focalpoint/focalpoint-gs-pi.pdf. Accessed September 17, 2012.
5. Elsheikh TM, Kirkpatrick JL, Cooper MK, et al. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy. Cancer Cytopathol. 2010;118:75-82.
6. US Food and Drug Administration. How laboratorians can safely calculate workload for FDA-approved semi-automated gynecologic cytology screening devices. Available at http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ TipsandArticlesonDeviceSafety/ucm220292.htm. Accessed September 17, 2012.
7. Levi AW, Chhieng DC, Schofield K, et al. Implementation of FocalPoint GS location-guided imaging system: experience in a clinical setting. Cancer Cytopathol. 2012;120:126-133.
8. Ellis K, Renshaw AA, Dudding N. Individual estimated sensitivity and workload for manual screening of SurePath gynecologic cytology. Diagn Cytopathol. 2012;40:95-97.
9. Renshaw AA, Elsheikh TM. Sensitivity and workload for manual and automated gynecologic screening: best current estimates. Diagn Cytopathol. 2011;39:647-650.
10. Roberts JM, Thurloe JK, Bowditch RC, et al. A three-armed trial of the ThinPrep Imaging System. Diagn Cytopathol. 2007;35:96-102.
11. Zhang FF, Banks HW, Langford SM, et al. Accuracy of ThinPrep Imaging System in detecting low-grade squamous intraepithelial lesions. Arch Pathol Lab Med. 2007;131:773-776. (Pubitemid 46726140)